Rheumatoide arthritis antikörper

1.

Farragher TM, Goodson NJ, Naseem H et al.: Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008; 58: 359–69. MEDLINE

2.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allart CF et al.: Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007; 146: 406–15.

3.

Emery P, Breedveld FC, Hall S et al.: Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind parallel treatment trial. Lancet 2008; 372: 375–82. MEDLINE

4.

Egerer K, Feist E, Burmester GR: The serological diagnosis of rheumatoid arthritis—antibodies to citrullinated antigens [Serologische Diagnostik der Rheumatoiden Arthritis – Antikörper gegen citrullinierte Antigene]. Dtsch Arztebl Int 2009; 106(10): 159–63.

5.

Syversen SW, Gaarder PI, Goll GL et al: High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008; 67: 212–7. MEDLINE

6.

Meyer O, Labarre C, Dougados M et al.: Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62: 120–6. MEDLINE

7.

Wiik AS: The immune response to citrullinated proteins in patients with rheumatoid arthritis: genetic, clinical, technical, and epidemiological aspects. Clin Rev Allergy Immunol 2007; 32: 13–22. MEDLINE

8.

van die Helm-van Mil AH, Huizinga TW: Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008; 10: 205. MEDLINE

9.

Yamamoto K, Yamada R: Lessons from a genom wide association study of rheumatoid arthritis. New Engl J Med. 2007; 357: 1250–1. MEDLINE

10.

Caspi D, Anouk M, Golan I et al.: Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Arthritis Rheum 2006; 55: 53–6. MEDLINE

11.

Bang H, Egerer K, Gauliard A et al.: Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007; 56: 2503-11. MEDLINE

12.

Mathsson L, Mullazehi M, Wick MC et al.: Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum 2008; 58: 36–45. MEDLINE